These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 16983521)

  • 21. A one year health economic model comparing transdermal fentanyl with sustained-release morphine in the treatment of chronic noncancer pain.
    Frei A; Andersen S; Hole P; Jensen NH
    J Pain Palliat Care Pharmacother; 2003; 17(2):5-26. PubMed ID: 14649386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Feasibility to treat pediatric cancer pain with analgesics for adults and their efficacy].
    Zhen ZJ; Sun XF; Xia Y; Ling JY; Zheng L; Luo WB; Lin H
    Ai Zheng; 2007 Aug; 26(8):866-9. PubMed ID: 17697549
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictors of long-acting opioid use and oral versus transdermal route among older Medicaid beneficiaries.
    Rigler SK; Shireman TI; Kallenbach L
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):91-9. PubMed ID: 17719511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of dosing frequency of sustained-release opioid preparations in patients with chronic nonmalignant pain.
    Gallagher RM; Welz-Bosna M; Gammaitoni A
    Pain Med; 2007; 8(1):71-4. PubMed ID: 17244106
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of opioids in the treatment of chronic non-cancer pain.
    Trescot AM; Glaser SE; Hansen H; Benyamin R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S181-200. PubMed ID: 18443639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transdermal buprenorphine in cancer pain and palliative care.
    Sittl R
    Palliat Med; 2006; 20 Suppl 1():s25-30. PubMed ID: 16764218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are there cost benefits to fentanyl for breakthrough pain?
    Davis MP
    J Pain Symptom Manage; 2012 Sep; 44(3):e1-2. PubMed ID: 22939453
    [No Abstract]   [Full Text] [Related]  

  • 28. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
    Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
    Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines.
    Trescot AM; Helm S; Hansen H; Benyamin R; Glaser SE; Adlaka R; Patel S; Manchikanti L
    Pain Physician; 2008 Mar; 11(2 Suppl):S5-S62. PubMed ID: 18443640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Economic evaluation of OROS hydromorphone for chronic pain: a Pan-European perspective.
    Hauber AB; Fleischmann J; Lothgren M; Wilson M; Lam A; Dubois D; Sabatowski R
    J Opioid Manag; 2011; 7(4):287-96. PubMed ID: 21957828
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphine or oxycodone tablets for pain?].
    Fredheim OM; Dale O; Kaasa S; Borchgrevink PC
    Tidsskr Nor Laegeforen; 2010 Aug; 130(15):1479-81. PubMed ID: 20706310
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain.
    Allan L; Hays H; Jensen NH; de Waroux BL; Bolt M; Donald R; Kalso E
    BMJ; 2001 May; 322(7295):1154-8. PubMed ID: 11348910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Switching from transdermal drugs: an observational "N of 1" study of fentanyl and buprenorphine.
    Mercadante S; Porzio G; Fulfaro F; Aielli F; Verna L; Ficorella C; Casuccio A; Riina S; Intravaia G; Mangione S
    J Pain Symptom Manage; 2007 Nov; 34(5):532-8. PubMed ID: 17629666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Transdermal fentanyl in treating severe painful mucositis caused by autologous hematopoietic stem cell transplantation].
    Huang HQ; Cai QQ; Lin XB; Wang BF; Bu Q; Gao Y; Peng YL
    Ai Zheng; 2007 Apr; 26(4):390-3. PubMed ID: 17430658
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National utilization of transdermal fentanyl among community-dwelling older people in Finland.
    Bell JS; Klaukka T; Ahonen J; Hartikainen S
    Am J Geriatr Pharmacother; 2009 Dec; 7(6):355-61. PubMed ID: 20129256
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of tapentadol immediate release for the treatment of acute pain.
    Kwong WJ; Ozer-Stillman I; Miller JD; Haber NA; Russell MW; Kavanagh S
    Clin Ther; 2010 Sep; 32(10):1768-81. PubMed ID: 21194601
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Economic evaluation of controlled-release oxycodone vs oxycodone-acetaminophen for osteoarthritis pain of the hip or knee.
    Marshall DA; Strauss ME; Pericak D; Buitendyk M; Codding C; Torrance GW
    Am J Manag Care; 2006 Apr; 12(4):205-14. PubMed ID: 16610922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A research-based guideline for appropriate use of transdermal fentanyl to treat chronic pain.
    Wakefield B; Johnson JA; Kron-Chalupa J; Paulsen L
    Oncol Nurs Forum; 1998 Oct; 25(9):1505-13. PubMed ID: 9802048
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Transdermal fentanyl].
    Lossignol D; Sternon J
    Rev Med Brux; 1998 Apr; 19(2):83-6. PubMed ID: 9643088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Driving ability under opioids: current assessment of published studies].
    Sabatowski R
    Dtsch Med Wochenschr; 2008 Jun; 133 Suppl 2():S25-8. PubMed ID: 18548365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.